{"id":"https://openalex.org/W4362489439","doi":"https://doi.org/10.1158/1535-7163.c.6543057","title":"Data from Combinatorial Inhibition of Focal Adhesion Kinase and BCL-2 Enhances Antileukemia Activity of Venetoclax in Acute Myeloid Leukemia","display_name":"Data from Combinatorial Inhibition of Focal Adhesion Kinase and BCL-2 Enhances Antileukemia Activity of Venetoclax in Acute Myeloid Leukemia","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362489439","doi":"https://doi.org/10.1158/1535-7163.c.6543057"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.c.6543057","doi":"https://doi.org/10.1158/1535-7163.c.6543057","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.c.6543057","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1535-7163.c.6543057","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010481978","display_name":"Xiangmeng Wang","orcid":"https://orcid.org/0000-0003-3643-3353","observed_orcids":["https://orcid.org/0000-0003-3643-3353"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiangmeng Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067312104","display_name":"Po Yee Mak","orcid":"https://orcid.org/0009-0003-0067-8989","observed_orcids":["https://orcid.org/0009-0003-0067-8989"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Po Yee Mak","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109657885","display_name":"Hong Mu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hong Mu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024761740","display_name":"Wenjing Tao","orcid":"https://orcid.org/0000-0002-2622-3486","observed_orcids":["https://orcid.org/0000-0002-2622-3486"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wenjing Tao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082923675","display_name":"Arvind U.K. Rao","orcid":"https://orcid.org/0000-0002-9613-426X","observed_orcids":["https://orcid.org/0000-0002-9613-426X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arvind Rao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017932845","display_name":"Visweswaran Ravikumar","orcid":"https://orcid.org/0000-0003-4670-3898","observed_orcids":["https://orcid.org/0000-0003-4670-3898"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ravikumar Visweswaran","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009423275","display_name":"Vivian R. Ruvolo","orcid":"https://orcid.org/0000-0003-4363-7258","observed_orcids":["https://orcid.org/0000-0003-4363-7258"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vivian Ruvolo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073675187","display_name":"Jonathan A. Pachter","orcid":"https://orcid.org/0000-0002-0263-474X","observed_orcids":["https://orcid.org/0000-0002-0263-474X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jonathan A. Pachter","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0263-474X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074838425","display_name":"David T. Weaver","orcid":"https://orcid.org/0000-0001-8398-3919","observed_orcids":["https://orcid.org/0000-0001-8398-3919"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David T. Weaver","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079262854","display_name":"Michael Andreeff","orcid":"https://orcid.org/0000-0002-1144-1958","observed_orcids":["https://orcid.org/0000-0002-1144-1958"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Andreeff","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1144-1958","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Bing Xu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bing Xu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5075486072","display_name":"Bing Z. Carter","orcid":"https://orcid.org/0000-0003-0076-0889","observed_orcids":["https://orcid.org/0000-0003-0076-0889"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bing Z. Carter","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12582","display_name":"Flavonoids in Medical Research","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/focal-adhesion-kinase","display_name":"focal adhesion kinase","score":0.8629999756813049},{"id":"https://openalex.org/keywords/bcl-2-inhibition","display_name":"BCL-2 inhibition","score":0.8619999885559082},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.9629999995231628},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9670000076293945},{"id":"https://openalex.org/keywords/vs-4718","display_name":"VS-4718","score":0.9070000052452087},{"id":"https://openalex.org/keywords/mcl-1","display_name":"Mcl-1","score":0.9279999732971191},{"id":"https://openalex.org/keywords/bcl-xl","display_name":"Bcl-xL","score":1.0},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7549999952316284},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.7680000066757202},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.5400000214576721},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.7680000066757202},{"id":"https://openalex.org/keywords/interferon-genes","display_name":"interferon genes","score":0.8600000143051147},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.8859999775886536},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.9639999866485596},{"id":"https://openalex.org/keywords/complex-karyotype","display_name":"complex karyotype","score":0.7680000066757202},{"id":"https://openalex.org/keywords/antileukemic-activity","display_name":"antileukemic activity","score":0.7680000066757202}],"concepts":[{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.7795579433441162},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.6558228731155396},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6064169406890869},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5806853175163269},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.5407125949859619},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.41384193301200867},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39953362941741943},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.37893906235694885},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31255626678466797},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.09635314345359802},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.c.6543057","doi":"https://doi.org/10.1158/1535-7163.c.6543057","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.c.6543057","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1535-7163.c.6543057.v1","doi":"https://doi.org/10.1158/1535-7163.c.6543057.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.c.6543057.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.c.6543057","doi":"https://doi.org/10.1158/1535-7163.c.6543057","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.c.6543057","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3025975123","https://openalex.org/W2739894552","https://openalex.org/W4405040535","https://openalex.org/W434671858","https://openalex.org/W4236630545","https://openalex.org/W2546530865","https://openalex.org/W2986170425","https://openalex.org/W4361954221","https://openalex.org/W4317254619","https://openalex.org/W2601746694"],"abstract_inverted_index":{"Abstract":[0],"Focal":[1],"adhesion":[2],"kinase":[3],"(FAK)":[4],"promotes":[5],"cancer":[6],"cell":[7],"growth":[8],"and":[9,33,62,67,80,88,106,127,137,148,160,163,180,218,232,234,245,248],"metastasis.":[10],"We":[11,69],"previously":[12],"reported":[13],"that":[14,71,212,235],"FAK":[15,75,217],"inhibition":[16,215],"by":[17,50,60,229],"the":[18,51,175,182,213],"selective":[19],"inhibitor":[20,53],"VS-4718":[21,35,72,84,90,130],"exerted":[22],"antileukemia":[23,221],"activities":[24],"in":[25,56,98,187,223,227,241],"acute":[26],"myeloid":[27],"leukemia":[28,134,157],"(AML).":[29],"The":[30,189,209],"mechanisms":[31],"involved,":[32],"whether":[34],"potentiates":[36],"efficacy":[37],"of":[38,65,184,195,216],"other":[39,246],"therapeutic":[40],"agents,":[41],"have":[42],"not":[43],"been":[44],"investigated.":[45],"Resistance":[46],"to":[47,95],"apoptosis":[48,97],"inducted":[49],"BCL-2":[52,219],"ABT-199":[54,94,153],"(venetoclax)":[55],"AML":[57,99,103,107,207,224,242],"is":[58],"mediated":[59],"preexisting":[61],"ABT-199\u2013induced":[63,86],"overexpression":[64],"MCL-1":[66,79,87,110,231],"BCL-XL.":[68,89,112],"observed":[70],"or":[73,111],"silencing":[74],"with":[76,93,124,152,243,252],"siRNA":[77],"decreased":[78,155,177],"BCL-XL":[81,233],"levels.":[82],"Importantly,":[83],"antagonized":[85],"markedly":[91,192],"synergized":[92],"induce":[96],"cells,":[100],"including":[101],"primary":[102],"CD34+":[104],"cells":[105,108],"overexpressing":[109],"In":[113],"a":[114,121,196],"patient-derived":[115],"xenograft":[116],"(PDX)":[117],"model":[118,199],"derived":[119],"from":[120,201],"patient":[122],"sample":[123],"NPM1/FLT3-ITD/TET2/DNMT3A/WT1":[125],"mutations":[126],"complex":[128,205],"karyotype,":[129],"statistically":[131],"significantly":[132],"reduced":[133],"tissue":[135,158],"infiltration":[136,159],"extended":[138,193],"survival":[139,165,194],"(72":[140],"vs.":[141,167],"control":[142,168],"36":[143,169],"days,":[144,170],"P":[145,171],"=":[146,172],"0.0002),":[147],"only":[149],"its":[150],"combination":[151,176,190,237],"effectively":[154],"systemic":[156],"circulating":[161],"blasts,":[162],"prolonged":[164],"(65.5":[166],"0.0119).":[173],"Furthermore,":[174],"NF\u03baB":[178],"signaling":[179],"induced":[181],"expression":[183],"IFN":[185],"genes":[186],"vivo.":[188],"also":[191],"second":[197],"PDX":[198],"developed":[200],"an":[202],"aggressive,":[203],"TP53-mutated":[204],"karyotype":[206],"sample.":[208],"data":[210],"suggest":[211],"combined":[214],"enhances":[220],"activity":[222],"at":[225],"least":[226],"part":[228],"suppressing":[230],"this":[236],"may":[238],"be":[239],"effective":[240],"TP53":[244],"mutations,":[247],"thus":[249],"benefit":[250],"patients":[251],"high-risk":[253],"AML.":[254]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}